NASDAQ Biotechnology Index (NBI) Market Capitalization
Explore all companies in the NASDAQ Biotechnology Index ranked by market capitalization
Total Market Cap: $1.54 Trillion Constituents: 263 Country: USA
Total Market Cap (USD)
$1.54 Trillion
Constituent Companies
263
Index Country
USA
| Rank | Company | Weight (%) | Market Cap (USD) | Sector | Industry | Price | 24h Change |
|---|---|---|---|---|---|---|---|
| 151 |
Amphastar P
NASDAQ:AMPH |
% | $665.68 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $19.51 | +0.52% |
| 152 |
Arvinas Inc
NASDAQ:ARVN |
% | $665.05 Million | Healthcare | Biotechnology | $12.01 | -2.20% |
| 153 |
Xencor Inc
NASDAQ:XNCR |
% | $630.08 Million | Healthcare | Biotechnology | $11.74 | -2.41% |
| 154 |
Tourmaline Bio Inc.
NASDAQ:TRML |
% | $629.86 Million | Healthcare | Biotechnology | $47.98 | +0.00% |
| 155 |
Phathom Pharmaceuticals Inc
NASDAQ:PHAT |
% | $620.30 Million | Healthcare | Biotechnology | $10.85 | +3.93% |
| 156 |
Cullinan Oncology LLC
NASDAQ:CGEM |
% | $605.86 Million | Healthcare | Biotechnology | $13.44 | -4.21% |
| 157 |
Esperion Therapeutics Inc
NASDAQ:ESPR |
% | $604.15 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $2.71 | +0.74% |
| 158 |
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX |
% | $580.60 Million | Healthcare | Biotechnology | $1.62 | +0.62% |
| 159 |
Janux Therapeutics Inc
NASDAQ:JANX |
% | $576.00 Million | Healthcare | Biotechnology | $14.05 | +1.22% |
| 160 |
Sana Biotechnology Inc
NASDAQ:SANA |
% | $571.42 Million | Healthcare | Biotechnology | $3.22 | -1.53% |
| 161 |
ArriVent BioPharma, Inc. Common Stock
NASDAQ:AVBP |
% | $558.63 Million | Healthcare | Biotechnology | $24.01 | -1.23% |
| 162 |
Kura Oncology Inc
NASDAQ:KURA |
% | $555.86 Million | Healthcare | Biotechnology | $8.58 | -1.72% |
| 163 |
Arbutus Biopharma Corp
NASDAQ:ABUS |
% | $542.95 Million | Healthcare | Biotechnology | $4.36 | +0.00% |
| 164 |
Inhibrx Biosciences, Inc.
NASDAQ:INBX |
% | $539.70 Million | Healthcare | Biotechnology | $69.71 | +0.65% |
| 165 |
Annexon Inc
NASDAQ:ANNX |
% | $537.40 Million | Healthcare | Biotechnology | $5.61 | -1.92% |
| 166 |
Zevra Therapeutics Inc.
NASDAQ:ZVRA |
% | $516.25 Million | Healthcare | Biotechnology | $9.90 | +0.30% |
| 167 |
Rigel Pharmaceuticals Inc
NASDAQ:RIGL |
% | $479.54 Million | Healthcare | Biotechnology | $26.38 | -0.64% |
| 168 |
Aquestive Therapeutics Inc
NASDAQ:AQST |
% | $460.10 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $4.11 | -1.67% |
| 169 |
Kalvista Pharmaceuticals Inc
NASDAQ:KALV |
% | $451.25 Million | Healthcare | Biotechnology | $16.56 | -1.55% |
| 170 |
Altimmune Inc
NASDAQ:ALT |
% | $450.83 Million | Healthcare | Biotechnology | $3.53 | -2.49% |
| 171 |
Sage Therapeutics Inc
NASDAQ:SAGE |
% | $445.41 Million | Healthcare | Biotechnology | $8.68 | +0.00% |
| 172 |
Compass Pathways Plc
NASDAQ:CMPS |
% | $444.83 Million | Healthcare | Medical Care Facilities | $6.06 | -3.96% |
| 173 |
CorMedix Inc
NASDAQ:CRMD |
% | $440.19 Million | Healthcare | Biotechnology | $6.46 | -1.22% |
| 174 |
Precigen Inc
NASDAQ:PGEN |
% | $434.08 Million | Healthcare | Biotechnology | $3.54 | +0.85% |
| 175 |
Alvotech
NASDAQ:ALVO |
% | $415.08 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $3.82 | +5.82% |
| 176 |
Anavex Life Sciences Corp
NASDAQ:AVXL |
% | $408.51 Million | Healthcare | Biotechnology | $4.55 | -3.40% |
| 177 |
Pacific Biosciences of California
NASDAQ:PACB |
% | $404.05 Million | Healthcare | Medical Devices | $1.38 | +1.47% |
| 178 |
Replimune Group Inc
NASDAQ:REPL |
% | $398.83 Million | Healthcare | Biotechnology | $7.00 | -4.89% |
| 179 |
Prothena Corporation plc
NASDAQ:PRTA |
% | $390.53 Million | Healthcare | Biotechnology | $9.00 | -1.85% |
| 180 |
Prime Medicine, Inc. Common Stock
NASDAQ:PRME |
% | $387.10 Million | Healthcare | Biotechnology | $3.71 | +1.09% |
| 181 |
Ironwood Pharmaceuticals Inc
NASDAQ:IRWD |
% | $384.72 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $3.25 | -3.56% |
| 182 |
Personalis Inc
NASDAQ:PSNL |
% | $374.63 Million | Healthcare | Diagnostics & Research | $7.12 | +4.86% |
| 183 |
Atea Pharmaceuticals Inc
NASDAQ:AVIR |
% | $364.79 Million | Healthcare | Biotechnology | $6.13 | +1.32% |
| 184 |
Regenxbio Inc
NASDAQ:RGNX |
% | $360.15 Million | Healthcare | Biotechnology | $8.64 | -1.71% |
| 185 |
Vanda Pharmaceuticals Inc
NASDAQ:VNDA |
% | $359.97 Million | Healthcare | Biotechnology | $8.60 | -2.38% |
| 186 |
4D Molecular Therapeutics Inc
NASDAQ:FDMT |
% | $354.75 Million | Healthcare | Biotechnology | $8.61 | +1.53% |
| 187 |
Allogene Therapeutics Inc
NASDAQ:ALLO |
% | $350.42 Million | Healthcare | Biotechnology | $2.27 | -6.97% |
| 188 |
Absci Corp
NASDAQ:ABSI |
% | $345.85 Million | Healthcare | Biotechnology | $3.03 | +21.20% |
| 189 |
Iteos Therapeutics Inc
NASDAQ:ITOS |
% | $339.96 Million | Healthcare | Biotechnology | $10.15 | +0.00% |
| 190 |
Silence Therapeutics PLC
NASDAQ:SLN |
% | $326.86 Million | Healthcare | Biotechnology | $6.91 | -5.99% |
| 191 |
MeiraGTx Holdings PLC
NASDAQ:MGTX |
% | $315.89 Million | Healthcare | Biotechnology | $7.65 | -0.52% |
| 192 |
Theravance Biopharma Inc
NASDAQ:TBPH |
% | $315.26 Million | Healthcare | Biotechnology | $13.92 | -0.07% |
| 193 |
Solid Biosciences LLC
NASDAQ:SLDB |
% | $310.51 Million | Healthcare | Biotechnology | $7.76 | +3.74% |
| 194 |
Lexeo Therapeutics, Inc. Common Stock
NASDAQ:LXEO |
% | $304.32 Million | Healthcare | Biotechnology | $6.38 | -2.89% |
| 195 |
Amarin Corporation PLC
NASDAQ:AMRN |
% | $303.32 Million | Healthcare | Drug Manufacturers - General | $15.52 | +0.65% |
| 196 |
Maravai Lifesciences Holdings Inc
NASDAQ:MRVI |
% | $285.91 Million | Healthcare | Biotechnology | $3.12 | -0.95% |
| 197 |
Keros Therapeutics Inc
NASDAQ:KROS |
% | $270.55 Million | Healthcare | Biotechnology | $11.34 | +2.81% |
| 198 |
Enanta Pharmaceuticals Inc
NASDAQ:ENTA |
% | $268.04 Million | Healthcare | Biotechnology | $13.27 | +2.79% |
| 199 |
Design Therapeutics Inc
NASDAQ:DSGN |
% | $257.69 Million | Healthcare | Biotechnology | $11.04 | +0.45% |
| 200 |
Neumora Therapeutics, Inc.
NASDAQ:NMRA |
% | $257.45 Million | Healthcare | Biotechnology | $2.83 | -1.39% |
Complete list of all companies in the NBI index ranked by market capitalization. Track index constituent performance and market values. View all indices